Denial of Inpatient Genetic Testing: A Study on Outpatient Yield and Outcomes
American Journal of Medical Genetics Part A · 2026
DOI: 10.1002/ajmga.70041 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, 2026. Verfasst von Cindy Y Canales und 6 weiteren Autor:innen. Beteiligte Einrichtung: The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, Texas, USA. Hauptthemen laut MEDLINE: Genetic Testing, Inpatients, Outpatients, Genetic Diseases, Inborn. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Genetic conditions suspected in children often require genetic testing for accurate diagnoses, but testing remains costly. Case management teams review genetic test requests to improve access for patients while reducing the financial burden for medical institutions. Limited data exist on the diagnostic yields of genetic testing in the inpatient versus outpatient setting and the impact to care denial of inpatient genetic testing may pose. This study investigates diagnostic yields between patients approved for versus denied inpatient genetic testing and its impact to care. One thousand and fifty‐two charts of children admitted inpatient who received a genetic consult between July 2018 and June 2023 were reviewed; charts of children that followed up at the outpatient genetics clinic after inpatient discharge were additionally reviewed. Collected data included recommendations, completion, and results of genetic testing, and management recommendations based on a diagnosis. Statistical analysis assessed differences between the groups. Private insurance holders and patients with no prematurity history were less likely to be approved for inpatient genetic testing. The outpatient group had nearly twice the diagnostic yield and management recommendations did not differ between the groups. Inclusion of genetic providers in the review of inpatient genetic testing requests should be considered to improve outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, Texas, USA.
- Department of Pediatrics, Division of Medical Genetics, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
- Department of Obstetrics, Gynecology, and Reproductive Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
ORCID-Profile: Cindy Y Canales, Theresa Wittman
Zitieren
APA
Canales, C. Y., Shields, K., Choates, M., Hillman, P., Farach, L., Wittman, T., & Leal, K. (2026). Denial of Inpatient Genetic Testing: A Study on Outpatient Yield and Outcomes. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmga.70041
Vancouver
Canales CY, Shields K, Choates M, Hillman P, Farach L, Wittman T, et al. Denial of Inpatient Genetic Testing: A Study on Outpatient Yield and Outcomes. American Journal of Medical Genetics Part A. 2026. doi:10.1002/ajmga.70041
BibTeX
@article{Canales2026,
author = {Canales, Cindy Y and Shields, Kathleen and Choates, Meagan and Hillman, Paul and Farach, Laura and Wittman, Theresa and Leal, Kathryn},
title = {Denial of Inpatient Genetic Testing: A Study on Outpatient Yield and Outcomes},
journal = {American Journal of Medical Genetics Part A},
year = {2026},
doi = {10.1002/ajmga.70041}
}
EUVIMED